Table 2 Laboratory results of the included COVID-19 patients after two sequential negative nucleic acid testing
N | Total | Moderate | Mild | P | |||
|---|---|---|---|---|---|---|---|
n | Median (IQR) | n | Median (IQR) | ||||
WBC count, × 109 /L | 51 | 5.78 (4.38, 7.70) | 31 | 5.90 (4.84, 8.39) | 20 | 5.62 (3.99, 7.39) | 0.298 |
Neutrophile granulocyte, % | 49 | 55.2 (47.9, 63.3) | 30 | 55.8 (46.9, 63.7) | 19 | 52.4 (41.3, 60) | 0.325 |
Lymphocyte count, ×109 /L | 46 | 2.01 (1.49, 2.53) | 28 | 1.99 (1.41, 2.90) | 18 | 2.07 (1.65, 2.34) | 0.839 |
Lymphocyte, % | 51 | 34.1 (27.9, 41.7) | 31 | 32.3 (23.9, 37.9) | 20 | 35.7 (29.4, 44.6) | 0.162 |
C-reactive protein, mg/L | 44 | 0.73 (0.34, 1.84) | 26 | 0.86 (0.36, 2.04) | 18 | 0.64 (0.21, 1.3) | 0.481 |
D-dimer, μg/mL | 20 | 0.27 (0.22, 0.42) | 13 | 0.25 (0.22, 0.43) | 7 | 0.28 (0.22, 0.39) | 0.838 |
Erythrocyte sedimentation rate, mm/h | 10 | 19 (3.75, 32) | 7 | 19 (4, 24) | 3 | 30 (2, 44) | 0.568 |
Lactate dehydrogenase, U/L | 37 | 362 (323.5, 424) | 23 | 354 (322, 416) | 14 | 369 (322, 448) | 0.650 |
Alanine aminotransferase, U/L | 43 | 21 (16, 36) | 27 | 22 (18, 46) | 16 | 20 (15, 34) | 0.606 |
Aspartate aminotransferase, U/L | 43 | 27 (22, 33) | 27 | 27 (23, 32) | 16 | 26 (20, 33) | 0.763 |